ON THE ROLE OF THE HPS GENE PRODUCT IN MELANOCYTES

HPS 基因产物在黑色素细胞中的作用

基本信息

  • 批准号:
    6532976
  • 负责人:
  • 金额:
    $ 21.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-08-01 至 2004-07-31
  • 项目状态:
    已结题

项目摘要

The Hermansky-Pudlak Syndrome (HPS) is a congenital, potentially fatal, multi-system disorder presenting with oculocutaneous albinism, a mild to severe bleeding diathesis, and ceroid storage disease. These characteristics result from aberrations in a specific group of cellular organelles, (i.e., the pigment granule of the melanocyte, the dense bodies of the platelet, and the lysosome/residual body of the reticular cell respectively). HPS is an autosomal recessive disease that is somewhat prevalent in the United States and relatively frequent in Puerto Rico (1:1800 affected). The single gene affected in HPS putatively regulates a common feature in the biosynthesis and/or maintenance of the three types of specific cellular organelles involved. In common, these organelles either originate and/or receive specific glycoproteins from the Golgi apparatus. Thus it is hypothesized that the HPS gene product regulates selective trafficking from the trans Golgi network to distinct target organelles. The gene for HPS has recently been cloned. The deduced amino acid sequence it encodes has no significant homologies with any known protein. Therefore, this molecule appears to be a unique protein. The HPS gene product does contain motifs suggestive of a signal sequence, transmembrane domains, glycosylation sites, cysteine rich areas, and several lysosome/endosome trafficking motifs. Thus it is hypothesized to be a glycoprotein synthesized at the RER and trafficked to the limiting membranes of the specific organelles discussed. We propose to confirm the ultimate site of localization of the HPS gene product and its mode of synthesis using the melanocyte system. In addition, we will investigate its role in melanization and identify a candidate binding partner it must use for the fusion/docking process in its selective trafficking function. Specifically, cultured human melanocytes will be assessed for the immunocytochemical localization and biosynthesis analysis of the HPS gene product using a panel of antibodies generated against the HPS gene product. In addition, melanoma cells transfected with the anti-sense HPS cDNA and melanocytes cultured from patients with HPS will be used as artificial and natural knock-out models respectively to analyze the concurrent alteration in trafficking of various melanocyte specific gene products. In addition, HPS melanocytes will be transfected with the sense HPS cDNA in an attempt to correct the morphological/translocation defect. Finally, immunoprecipitation/immunoblotting experiments along with the Yeast Two-Hybrid system will be utilized to identify proteins that bind to the HPS gene product as candidate molecules that co-operate in the targeting process. These studies will contribute to our knowledge of cellular trafficking in general and the pathophysiology of HPS in specific.
Hermansky-Pudlak综合征(HPS)是一种先天性、潜在致命的多系统疾病,表现为眼皮肤白化病、轻度至重度出血素质和蜡样物质沉积病。 这些特征是由一组特定的细胞器中的畸变引起的,(即,黑素细胞的色素颗粒、血小板的致密体和网状细胞的溶酶体/残余体)。 HPS是一种常染色体隐性遗传疾病,在美国较为普遍,在波多黎各相对常见(1:1800患病)。 在HPS pupulum中受影响的单个基因调节所涉及的三种类型的特定细胞器的生物合成和/或维持中的共同特征。 通常,这些细胞器起源于高尔基体和/或从高尔基体接收特定的糖蛋白。 因此,假设HPS基因产物调节从transGolgi网络到不同靶细胞器的选择性运输。 HPS的基因最近已被克隆。 其编码的氨基酸序列与已知的蛋白质没有明显的同源性。 因此,这种分子似乎是一种独特的蛋白质。HPS基因产物确实含有提示信号序列、跨膜结构域、糖基化位点、富含半胱氨酸的区域和几个溶酶体/内体运输基序的基序。 因此,它被假设为在RER合成的糖蛋白,并被运输到所讨论的特定细胞器的限制膜。我们建议使用黑素细胞系统确认HPS基因产物的最终定位位点及其合成模式。 此外,我们将调查它在黑化中的作用,并确定一个候选的结合伙伴,它必须使用的融合/对接过程中,其选择性贩运功能。 具体地,将使用针对HPS基因产物产生的一组抗体,评估培养的人黑素细胞的HPS基因产物的免疫细胞化学定位和生物合成分析。 此外,用反义HPS cDNA转染的黑色素瘤细胞和从HPS患者培养的黑色素细胞将分别用作人工和天然敲除模型,以分析各种黑色素细胞特异性基因产物运输的同时改变。 此外,HPS黑素细胞将用有义HPS cDNA转染,以试图纠正形态学/易位缺陷。 最后,免疫沉淀/免疫印迹实验沿着酵母双杂交系统将用于鉴定结合HPS基因产物的蛋白质作为在靶向过程中协同作用的候选分子。 这些研究将有助于我们的知识,细胞贩运的一般和病理生理学的HPS的具体。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Melanocytes derived from patients with Hermansky-Pudlak Syndrome types 1, 2, and 3 have distinct defects in cargo trafficking.
来自 1 型、2 型和 3 型赫曼斯基-普德拉克综合征患者的黑素细胞在货物运输方面具有明显的缺陷。
  • DOI:
    10.1111/j.0022-202x.2004.23585.x
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Richmond,Bonnie;Huizing,Marjan;Knapp,Jill;Koshoffer,Amy;Zhao,Yang;Gahl,WilliamA;Boissy,RaymondE
  • 通讯作者:
    Boissy,RaymondE
Association of the Hermansky-Pudlak syndrome type-3 protein with clathrin.
Hermansky-Pudlak综合征3型蛋白与网格蛋白的关联。
  • DOI:
    10.1186/1471-2121-6-33
  • 发表时间:
    2005-09-13
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Helip-Wooley, A;Westbroek, W;Dorward, H;Mommaas, M;Boissy, RE;Gahl, WA;Huizing, M
  • 通讯作者:
    Huizing, M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAYMOND E BOISSY其他文献

RAYMOND E BOISSY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAYMOND E BOISSY', 18)}}的其他基金

The composition and function of BLOC-2 in melanogenesis
BLOC-2在黑素生成中的组成和功能
  • 批准号:
    7618445
  • 财政年份:
    2008
  • 资助金额:
    $ 21.58万
  • 项目类别:
The composition and function of BLOC-2 in melanogenesis
BLOC-2在黑素生成中的组成和功能
  • 批准号:
    7450079
  • 财政年份:
    2008
  • 资助金额:
    $ 21.58万
  • 项目类别:
2004 National Vitiligo Foundation Scientific Conference
2004年国家白癜风基金会科学会议
  • 批准号:
    6759710
  • 财政年份:
    2004
  • 资助金额:
    $ 21.58万
  • 项目类别:
PHENOLS/CATECHOLS IN OCCUPATIONAL/CONTACT VITILIGO SKIN
职业/接触性白癜风皮肤中的酚类/儿茶酚
  • 批准号:
    6532985
  • 财政年份:
    2000
  • 资助金额:
    $ 21.58万
  • 项目类别:
PHENOLS/CATECHOLS IN OCCUPATIONAL/CONTACT VITILIGO SKIN
职业/接触性白癜风皮肤中的酚类/儿茶酚
  • 批准号:
    6375223
  • 财政年份:
    2000
  • 资助金额:
    $ 21.58万
  • 项目类别:
PHENOLS/CATECHOLS IN OCCUPATIONAL/CONTACT VITILIGO SKIN
职业/接触性白癜风皮肤中的酚类/儿茶酚
  • 批准号:
    6199514
  • 财政年份:
    2000
  • 资助金额:
    $ 21.58万
  • 项目类别:
ON THE ROLE OF THE HPS GENE PRODUCT IN MELANOCYTES
HPS 基因产物在黑色素细胞中的作用
  • 批准号:
    2903040
  • 财政年份:
    1999
  • 资助金额:
    $ 21.58万
  • 项目类别:
ON THE ROLE OF THE HPS GENE PRODUCT IN MELANOCYTES
HPS 基因产物在黑色素细胞中的作用
  • 批准号:
    6375136
  • 财政年份:
    1999
  • 资助金额:
    $ 21.58万
  • 项目类别:
ON THE ROLE OF THE HPS GENE PRODUCT IN MELANOCYTES
HPS 基因产物在黑色素细胞中的作用
  • 批准号:
    6171138
  • 财政年份:
    1999
  • 资助金额:
    $ 21.58万
  • 项目类别:
TYROSINASE RELATED PROTEIN-1 AND BROWN OCA
酪氨酸酶相关蛋白-1 和棕色 OCA
  • 批准号:
    2732867
  • 财政年份:
    1996
  • 资助金额:
    $ 21.58万
  • 项目类别:

相似海外基金

Retinal Contributions to Vision Loss in Albinism
视网膜对白化病视力丧失的影响
  • 批准号:
    10652487
  • 财政年份:
    2022
  • 资助金额:
    $ 21.58万
  • 项目类别:
A Human Rights and Equity-Oriented Response to the Birth Stories of Families Impacted by Albinism in Sub-Saharan Africa: Intersectoral Partnerships for Enhanced Health Professions' Education
对撒哈拉以南非洲地区受白化病影响的家庭的出生故事采取以人权和公平为导向的应对措施:加强卫生专业教育的部门间伙伴关系
  • 批准号:
    463437
  • 财政年份:
    2022
  • 资助金额:
    $ 21.58万
  • 项目类别:
    Operating Grants
Retinal Contributions to Vision Loss in Albinism
视网膜对白化病视力丧失的影响
  • 批准号:
    10464283
  • 财政年份:
    2022
  • 资助金额:
    $ 21.58万
  • 项目类别:
Function of albinism gene oca2 in non-melanocyte cell development
白化病基因oca2在非黑素细胞发育中的作用
  • 批准号:
    10450112
  • 财政年份:
    2021
  • 资助金额:
    $ 21.58万
  • 项目类别:
SG: Uncovering the contributions of albinism to the evolution of the Mexican cavefish
SG:揭示白化病对墨西哥洞穴鱼进化的贡献
  • 批准号:
    2147597
  • 财政年份:
    2021
  • 资助金额:
    $ 21.58万
  • 项目类别:
    Standard Grant
Function of albinism gene oca2 in non-melanocyte cell development
白化病基因oca2在非黑素细胞发育中的作用
  • 批准号:
    10303820
  • 财政年份:
    2021
  • 资助金额:
    $ 21.58万
  • 项目类别:
Oral Levodopa treatment in Improving Visual development in Infants and young children with Albinism-the OLIVIA study
口服左旋多巴治疗改善白化病婴幼儿视觉发育——OLIVIA研究
  • 批准号:
    MR/R007640/1
  • 财政年份:
    2018
  • 资助金额:
    $ 21.58万
  • 项目类别:
    Fellowship
SG: Uncovering the contributions of albinism to the evolution of the Mexican cavefish
SG:揭示白化病对墨西哥洞穴鱼进化的贡献
  • 批准号:
    1754231
  • 财政年份:
    2018
  • 资助金额:
    $ 21.58万
  • 项目类别:
    Standard Grant
Un/doing Albinism: Recodings of a bodily difference through historically shifting frames
消除/消除白化病:通过历史变化的框架重新编码身体差异
  • 批准号:
    310496337
  • 财政年份:
    2016
  • 资助金额:
    $ 21.58万
  • 项目类别:
    Research Units
Chemical chaperone therapy for oculocutaneous albinism
眼皮肤白化病的化学伴侣疗法
  • 批准号:
    16K10170
  • 财政年份:
    2016
  • 资助金额:
    $ 21.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了